Keywords: product, news, brief, glaxo, wellcome, filed, approval

Product News In Brief

Article | 25 June 1998

Print This

Glaxo Wellcome has filed for approval of its antiviral drug lamivudineas a treatment for chronic hepatitis B in the USA. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in